These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38278788)

  • 1. Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins.
    Fu C; Liu Y; Walt C; Rasheed S; Bader CD; Lukat P; Neuber M; Haeckl FPJ; Blankenfeldt W; Kalinina OV; Müller R
    Nat Commun; 2024 Jan; 15(1):791. PubMed ID: 38278788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
    Kling A; Lukat P; Almeida DV; Bauer A; Fontaine E; Sordello S; Zaburannyi N; Herrmann J; Wenzel SC; König C; Ammerman NC; Barrio MB; Borchers K; Bordon-Pallier F; Brönstrup M; Courtemanche G; Gerlitz M; Geslin M; Hammann P; Heinz DW; Hoffmann H; Klieber S; Kohlmann M; Kurz M; Lair C; Matter H; Nuermberger E; Tyagi S; Fraisse L; Grosset JH; Lagrange S; Müller R
    Science; 2015 Jun; 348(6239):1106-12. PubMed ID: 26045430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Analysis of an Antibacterial Cyclodepsipeptide Active against Mycobacterium tuberculosis by a Combined ROE and RDC Analysis.
    Fredersdorf M; Kurz M; Bauer A; Ebert MO; Rigling C; Lannes L; Thiele CM
    Chemistry; 2017 Apr; 23(24):5729-5735. PubMed ID: 28106929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sliding Clamp of DNA Polymerase III as a Drug Target for TB Therapy: Comprehensive Conformational and Binding Analysis from Molecular Dynamic Simulations.
    Machaba KE; Cele FN; Mhlongo NN; Soliman ME
    Cell Biochem Biophys; 2016 Dec; 74(4):473-481. PubMed ID: 27651172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplanecins, novel antimycobacterial antibiotics from Actinoplanes awajinensis subsp. mycoplanecinus subsp. nov. II. Isolation, physico-chemical characterization and biological activities of mycoplanecin A.
    Nakajima M; Torikata A; Ichikawa Y; Katayama T; Shiraishi A; Haneishi T; Arai M
    J Antibiot (Tokyo); 1983 Aug; 36(8):961-6. PubMed ID: 6630066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis.
    Song L; Jenner M; Masschelein J; Jones C; Bull MJ; Harris SR; Hartkoorn RC; Vocat A; Romero-Canelon I; Coupland P; Webster G; Dunn M; Weiser R; Paisey C; Cole ST; Parkhill J; Mahenthiralingam E; Challis GL
    J Am Chem Soc; 2017 Jun; 139(23):7974-7981. PubMed ID: 28528545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.
    Patel K; Tyagi C; Goyal S; Jamal S; Wahi D; Jain R; Bharadvaja N; Grover A
    Comput Biol Chem; 2015 Dec; 59 Pt A():37-47. PubMed ID: 26410242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
    Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
    Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
    Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.
    Ma J; Huang H; Xie Y; Liu Z; Zhao J; Zhang C; Jia Y; Zhang Y; Zhang H; Zhang T; Ju J
    Nat Commun; 2017 Aug; 8(1):391. PubMed ID: 28855504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.
    Hegymegi-Barakonyi B; Székely R; Varga Z; Kiss R; Borbély G; Németh G; Bánhegyi P; Pató J; Greff Z; Horváth Z; Mészáros G; Marosfalvi J; Erōs D; Szántai-Kis C; Breza N; Garavaglia S; Perozzi S; Rizzi M; Hafenbradl D; Ko M; Av-Gay Y; Klebl BM; Orfi L; Kéri G
    Curr Med Chem; 2008; 15(26):2760-70. PubMed ID: 18991635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of DNA polymerase III β sliding clamp from Mycobacterium tuberculosis.
    Gui WJ; Lin SQ; Chen YY; Zhang XE; Bi LJ; Jiang T
    Biochem Biophys Res Commun; 2011 Feb; 405(2):272-7. PubMed ID: 21219854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplanecins, novel antimycobacterial antibiotics from Actinoplanes awajinensis subsp. mycoplanecinus subsp. nov. III. Structural determination of mycoplanecin A.
    Nakajima M; Torikata A; Tamaoki H; Haneishi T; Arai M; Kinoshita T; Kuwano H
    J Antibiot (Tokyo); 1983 Aug; 36(8):967-75. PubMed ID: 6630067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
    Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Levels of the Escherichia coli
    Babu VMP; Homiski C; Scotland MK; Chodavarapu S; Kaguni JM; Sutton MD
    J Bacteriol; 2021 Nov; 203(23):e0030421. PubMed ID: 34543109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
    Yan X; Lv Z; Wen J; Zhao S; Xu Z
    Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.